Volume 23 Issue 11
Nov.  2025
Turn off MathJax
Article Contents
XIE Junzhe, ZHANG Chunlian, FAN Jifeng, FENG Xiaoyun. Distribution and management strategies of thyroid dysfunction among elderly residents based on health examinations[J]. Chinese Journal of General Practice, 2025, 23(11): 1896-1899. doi: 10.16766/j.cnki.issn.1674-4152.004255
Citation: XIE Junzhe, ZHANG Chunlian, FAN Jifeng, FENG Xiaoyun. Distribution and management strategies of thyroid dysfunction among elderly residents based on health examinations[J]. Chinese Journal of General Practice, 2025, 23(11): 1896-1899. doi: 10.16766/j.cnki.issn.1674-4152.004255

Distribution and management strategies of thyroid dysfunction among elderly residents based on health examinations

doi: 10.16766/j.cnki.issn.1674-4152.004255
Funds:

 20ZR1444400

 2023SJKJGG043

  • Received Date: 2024-10-23
    Available Online: 2026-01-07
  •   Objective  The prevalence of thyroid dysfunction increases with age, but the impact of different thyroid stimulating hormone (TSH) thresholds on health outcomes remains controversial. This study investigates the distribution of thyroid dysfunction and explore primary care management strategies based on the health examination data of 3 830 elderly residents from Dongjing Town, Songjiang District, Shanghai, in 2023.  Methods  Subclinical hypothyroidism (SCH) was defined using TSH cut-offs of 4.2, 6.0, 8.0, and 10.0 mIU/L. Health status and cognitive function were compared among residents with different thyroid function states, and clinical and laboratory indicators were analyzed between the SCH group and the euthyroid control group.  Results  At all TSH thresholds, the red cell distribution width (RDW) in the SCH group was significantly higher than in controls (P < 0.05). When TSH≥6.0 mIU/L, the prevalence of cardiac enlargement in the SCH group was 45.6% (47/103), higher than 29.8% (31/104) in control group (χ2=5.518, P=0.019). When TSH≥8.0 mIU/L, hypertension prevalence was 52.7% (29/55) in the SCH group versus 30.9% (17/55) in control group (χ2=5.380, P=0.020), while diabetes prevalence was 5.5% (3/55) versus 18.2% (10/55, χ2=4.274, P=0.039). When TSH≥10.0 mIU/L, significant differences were observed between SCH and control groups in waist circumference, lipid profiles, and the incidence of sinus bradycardia (P < 0.05).  Conclusion  Elderly residents in Dongjing Town, Songjiang District, Shanghai, have better thyroid health than the national average. When TSH < 10.0 mIU/L, overall health status and cognitive function show no significant differences. Regular monitoring of elderly hypothyroid patients is recommended to prevent iatrogenic risks from overtreatment.

     

  • loading
  • [1]
    ZOU Y T, WANG D C, CHENG X Q, et al. Reference intervals for thyroid-associated hormones and the prevalence of thyroid diseases in the Chinese population[J]. Ann Lab Med, 2021, 41(1): 77-85. doi: 10.3343/alm.2021.41.1.77
    [2]
    中华医学会老年医学分会老年内分泌代谢疾病学组, 中华医学会内分泌学分会甲状腺学组. 中国老年人甲状腺疾病诊疗专家共识(2021)[J]. 中华老年医学杂志, 2021, 40(5): 529-549.

    Expert Consensus on Diagnosis and Treatment for Elderly with Thyroid Diseases in China(2021)[J]. Chinese Journal of Geriatrics, 2021, 40(5): 529-549.
    [3]
    CHAKER L, RAZVI S, BENSENOR I M, et al. Hypothyroidism[J]. Nat Rev Dis Primers, 2022, 8(1): 1-17. doi: 10.1038/s41572-022-00335-z
    [4]
    BIONDI B, CAPPOLA A R. Subclinical hypothyroidism in older individuals[J]. Lancet Diabetes Endocrinol, 2022, 10(2): 129-141. doi: 10.1016/S2213-8587(21)00285-0
    [5]
    PATRIZIO A, FERRARI S M, ELIA G, et al. Hypothyroidism and metabolic cardiovascular disease[J]. Front Endocrinol, 2024, 15: 1408684. DOI: 10.3389/fendo.2024.1408684.
    [6]
    KAUSHIK A, AGRAWAL M. Relationship between subclinical hypothyroidism and the risk of cardiovascular complications[J]. Cureus, 2023, 15(1): e33708. DOI: 10.7759/cureus.33708.
    [7]
    ROSS D S. Treating hypothyroidism is not always easy: when to treat subclinical hypothyroidism, TSH goals in the elderly, and alternatives to levothyroxine monotherapy[J]. J Intern Med, 2022, 291(2): 128-140. doi: 10.1111/joim.13410
    [8]
    倪秀石, 吴方, 宋娟, 等. 老年人认知障碍评估中国专家共识(2022)[J]. 中华老年医学杂志, 2022, 41(12): 1430-1440.

    NI X S, WU F, SONG J, et al. Chinese expert consensus on assessment for cognitive impairment in the elderly[J]. Chinese Journal of Geriatrics, 2022, 41(12): 1430-1440.
    [9]
    李丽, 于德华, 马瑜, 等. 上海市某区50岁及以上居民甲状腺结节患病率与影响因素调查[J]. 中华全科医学, 2022, 20(8): 1360-1362. doi: 10.16766/j.cnki.issn.1674-4152.002597

    LI L, YU D H, MA Y, et al. Prevalence and influencing factors of thyroid nodule amongst residents aged 50 and above in Shanghai community[J]. Chinese Journal of General Practice, 2022, 20(8): 1360-1362. doi: 10.16766/j.cnki.issn.1674-4152.002597
    [10]
    URGATZ B, RAZVI S. Subclinical hypothyroidism, outcomes and management guidelines: a narrative review and update of recent literature[J]. Curr Med Res Opin, 2023, 39(3): 351-365. doi: 10.1080/03007995.2023.2165811
    [11]
    LEE S Y, PEARCE E N. Hyperthyroidism: a review[J]. JAMA, 2023, 330(15): 1472-1483. doi: 10.1001/jama.2023.19052
    [12]
    VAN HEEMST D. The ageing thyroid: implications for longevity and patient care[J]. Nat Rev Endocrinol, 2024, 20(1): 5-15. doi: 10.1038/s41574-023-00911-7
    [13]
    VAN VLIET N A, VAN HEEMST D, ALMEIDA O P, et al. Association of thyroid dysfunction with cognitive function: an individual participant data analysis[J]. JAMA Intern Med, 2021, 181(11): 1440-1450. doi: 10.1001/jamainternmed.2021.5078
    [14]
    SZLEJF C, SUEMOTO C K, JANOVSKY C C P S, et al. Subtle thyroid dysfunction is not associated with cognitive decline: results from the ELSA-Brasil[J]. J Alzheimers Dis, 2021, 81(4): 1529-1540. doi: 10.3233/JAD-210018
    [15]
    李昕嵘. 老年人TSH水平与临床指标及代谢组学的相关性研究[D]. 大连: 大连医科大学, 2022.

    LI X R. Correlation between TSH level and clinical indicators?metabolomics in the elderly[D]. Dalian: Dalian Medical University, 2022.
    [16]
    DENG B, YUAN Y, ZHONG M, et al. The relationship between metabolic parameters, age, and thyroid status: a cross-sectional study-based national survey of iodine nutrition, thyroid disease[J]. Risk Manag Health Policy, 2021, 14: 1723-1730. doi: 10.2147/RMHP.S306122
    [17]
    王丽静, 陈丽, 童周欣, 等. 以全血细胞减少为首诊的甲状腺功能减退症一例[J]. 新医学, 2023, 54(10): 760-763.

    WANG L J, CHEN L, TONG Z X, et al. Pancytopenia as an initial manifestation of hypothyroidism: a case report[J]. Journal of New Medicine, 2023, 54(10): 760-763.
    [18]
    ZHOU G W, AI Y Q, GUO S, et al. Association between red blood cell distribution width and thyroid function[J]. Front Endocrinol, 2022, 12: 807482. DOI: 10.3389/fendo.2021.807482.
    [19]
    HARRAR S, MHIRIG I, BOUFARES Y E A, et al. Lipid profile perturbations associated with subclinical hypothyroidism: a descriptive study[J]. Cureus, 2024, 16(4): e58181. DOI: 10.7759/cureus.58181.
    [20]
    BOSMA M, DU PUY R S, BALLIEUX B E P B. Screening for thyroid dysfunction with free T4 instead of thyroid stimulating hormone (TSH) improves efficiency in older adults in primary care[J]. Age Ageing, 2022, 51(9): afac215. DOI: 10.1093/ageing/afac215.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Article Metrics

    Article views (40) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return